Developing SABRE as an analytical tool in NMR
Lyrelle Stacey Lloyd
A thesis submitted for the degree of doctor of philosophy
Department of Chemistry
University of York
March 2013
2
Abstract
Work presented in this thesis centres around the application of the new hyperpolarisation technique, SABRE, within nuclear magnetic resonance spectroscopy, focusing on optimisation of the technique to characterise small organic molecules. While pyridine was employed as a model substrate, studies on a range of molecules are investigated including substituted pyridines, quinolines, thiazoles and indoles are detailed.
Initial investigations explored how the properties of the SABRE catalyst effect the extent of polarisation transfer exhibited. The most important of these properties proved to be the rate constants for loss of pyridine and hydrides as these define the contact time of pyridine with the para hydrogen derived hydride ligands in the metal template. The effect of changing the temperature, solvent or concentration of substrate or catalyst are rationalised. For instance, the catalyst ICy(a) exhibits relatively slow ligand exchange rates and increasing the temperature during hyperpolarisation increases the observed signal enhancements.
These studies have revealed a second polarisation transfer template can be used with SABRE in which two substrate molecules are bound. This allows the possibility of investigation of larger substrates which might otherwise be too sterically encumbered to bind.
Another significant advance relates to the first demonstration that SABRE can be used in conjunction with an automated system designed with Bruker allowing the acquisition of scan averaged, phase cycled and traditional 2D spectra. The system also allowed investigations into the effect of the polarisation transfer field and application of that knowledge to collect single scan 13 C data for characterisation. The successful acquisition of 1H NOESY, 1H 1H COSY, 1H 13 C 2D and ultrafast 1H 1H COSY NMR sequences is detailed for a 10 mM concentration sample, with 1H data collected for a 1 mM sample.
A range of studies which aim to demonstrate the applicability of SABRE to the characterisation of small molecules and pharmaceuticals have been conducted. 3
Table of Contents
Developing SABRE as an analytical tool in NMR ...... 1
Abstract ...... 2
Table of Contents ...... 3
List of Figures ...... 20
List of Tables...... 44
List of Equations ...... 53
Acknowledgements ...... 54
Declaration ...... 55
1 Chapter 1 – Introduction ...... 56
1.1 NMR spectroscopy ...... 56
1.1.1 NMR spectroscopy ...... 57
1.1.2 Increasing sensitivity of NMR through instrumental developments ...... 58
1.2 Hyperpolarisation in NMR ...... 60
1.2.1 Hyperpolarisation ...... 60
1.2.2 Brute force ...... 60
1.2.3 Optical pumping ...... 62
1.2.3.1 Optical pumping in NMR ...... 63
1.2.3.2 Optical pumping in MRI ...... 66
1.2.4 Dynamic nuclear polarisation ...... 68
1.2.5 Para hydrogen induced polarisation ...... 71 4
1.2.5.1 Para hydrogen applied to NMR spectroscopy ...... 71
1.2.5.2 Inorganic applications of PHIP ...... 74
1.2.5.3 Biological applications of PHIP ...... 75
1.2.5.4 Comparison of PASADENA and ALTADENA ...... 78
1.2.6 Signal amplification by reversible exchange ...... 79
1.2.6.1 Introduction to SABRE ...... 79
1.2.6.2 Theory behind transfer ...... 80
1.2.6.3 The phosphine ligand vs. the carbene ligand ...... 81
1.2.6.4 Phosphine based catalysts...... 81
1.2.6.5 Crabtree’s catalyst applied to SABRE ...... 84
1.2.6.6 Carbene based catalysts ...... 87
1.2.6.7 Carbene analogues of Crabtree’s catalyst applied to SABRE ...... 89
1.2.7 Only Para hydrogen SpectroscopY (OPSY) ...... 90
1.2.7.1 Introduction to OPSY ...... 90
1.3 Experimental considerations ...... 90
1.3.1 Production of para hydrogen ...... 90
1.3.2 Description of observed signals ...... 91
1.3.3 NMR described in terms of product operators ...... 93
1.3.3.1 Introduction to product operator terms 85 ...... 93
1.3.3.2 Using product operators to understand para hydrogen induced polarisation (PHIP) ...... 96 5
1.3.3.3 Using product operators to understand the 1H OPSY NMR sequences 86 ...... 97
1.4 Thesis aims ...... 97
2 Chapter 2 Catalyst synthesis ...... 101
2.1 Introduction ...... 101
2.1.1 Required properties of a SABRE catalyst ...... 101
2.1.2 Literature based SABRE results in which phosphine based catalysts are used ...... 102
2.1.3 Progression from phosphine based SABRE catalysts to carbene based SABRE catalysts ...... 104
2.1.4 Literature based SABRE results in which carbene based catalysts are used ...... 107
2.2 Experimental considerations ...... 107
2.2.1 Terminology ...... 107
2.2.1.1 SABRE using an NMR tube – the shake method (method 1) ...... 107
2.2.1.2 SABRE using a flow probe – the flow method (method 2) ...... 108
2.2.1.3 Comparison of method 1 to method 2 ...... 111
2.2.1.4 Considerations when discussing the effect of the magnetic field of polarisation ...... 112
2.2.1.5 Effect of changing the sign of magnetic field of polarisation on resultant 1H NMR spectra ...... 113
2.2.1.6 Calculation of enhancements ...... 114
2.2.1.7 Catalyst forms ...... 115 6
2.2.2 Effect of method 1 on the resultant 1H NMR spectra obtained without incorporation of enriched para hydrogen ...... 116
2.2.3 Reproducibility of NMR spectra when SABRE is implemented ...... 118
2.2.3.1 Reproducibility of method 1 ...... 118
2.2.3.2 Reproducibility of method 2 ...... 119
2.2.4 Mechanism of activation of SABRE catalysts ...... 120
2.2.5 Mechanism of reversible exchange of active species ...... 122
2.3 Effect of changing the carbene ligand on polarisation transfer efficiency ..... 123
2.3.1 Synthesis ...... 124
2.3.2 Comparison of structural properties ...... 124
2.3.2.1 Comparison of TEP, cone angle and buried volume of PCy 3, IMes, SIMes and ICy ...... 124
2.3.2.2 Comparison of IMes(a) , SIMes(a) and ICy(a) ...... 126
2.3.2.3 Comparison of the active hydrogenation products of IMes(a) , SIMes(a) and ICy(a) ...... 130
2.3.3 Comparison of ligand exchange rate constants and activation parameters of IMes(a) , SIMes(a) and ICy(a) ...... 132
2.3.3.1 Thermodynamic activation parameters observed for the loss of pyridine trans to the hydride ligands from hydrogenated IMes(a) , SIMes(a) and ICy(a) ...... 133
2.3.3.2 Thermodynamic activation parameters observed for the loss of hydride ligands from hydrogenated IMes(a) , SIMes(a) and ICy(a) in the presence of pyridine ...... 134
2.3.4 Comparison of polarisation transfer efficiency into pyridine of IMes(a) , SIMes(a) and ICy(a) ...... 135 7
2.4 Summary ...... 137
3 Chapter 3 Investigation of SABRE effect...... 139
3.1 Introduction ...... 139
3.2 Effect of magnetic field during the polarisation transfer step on polarisation transfer efficiency...... 139
3.2.1 Effect of magnetic field during the polarisation transfer step on polarisation transfer efficiency into pyridine ...... 142
3.2.2 Effect of magnetic field during the polarisation transfer step on polarisation transfer efficiency into deuterated pyridines ...... 143
3.3 Effect of temperature during the polarisation transfer step on polarisation transfer efficiency...... 145
3.3.1 Effect of changing the temperature of polarisation transfer efficiency into pyridine using IMes(a) ...... 147
3.3.2 Effect of changing the temperature of polarisation transfer efficiency into pyridine using SIMes(a) ...... 148
3.3.3 Effect of changing the temperature of polarisation transfer efficiency into pyridine using ICy(a) ...... 150
3.3.4 Comparison of the effect of temperature on the polarisation transfer efficiency into pyridine using IMes(a) , SIMes(a) and ICy(a) ...... 151
3.4 Effect of concentration during the polarisation transfer step on polarisation transfer efficiency...... 152
3.4.1 Effect of concentration when ratio of pyridine to catalyst remains constant on polarisation transfer efficiency ...... 154
3.4.2 Effect of concentration when concentration of catalyst remains constant on polarisation transfer efficiency ...... 160
3.5 Effect of solvent on polarisation transfer efficiency ...... 165 8
3.6 Summary ...... 167
4 Chapter 4 Optimisation of quinoline ...... 170
4.1 Introduction ...... 170
4.1.1 Quinoline analogues as drugs...... 170
4.1.1.1 Quinine and quinidine ...... 170
4.1.1.2 Chloroquine and hydroxychloroquine ...... 172
4.1.1.3 8 hydroxyquinoline analogues ...... 175
4.1.2 Characterisation of quinoline in methanol ...... 176
4.2 Initial studies into polarisation transfer efficiency into quinoline ...... 177
4.2.1 Effect of changing catalyst on polarisation transfer efficiency into quinoline ...... 177
4.2.2 Characterisation of IMes(c) hydrogenated in the presence of quinoline 179
4.2.3 Rate constants and thermodynamic activation parameters of IMes(c) hydrogenated in the presence of quinoline...... 181
4.2.3.1 Thermodynamic activation parameters observed for the loss of hydride ligands from IMes(c) hydrogenated in the presence of quinoline ...... 181
4.2.3.2 Thermodynamic activation parameters observed for the loss of quinoline ligands from hydrogenated IMes(c) ...... 182
4.3 Further optimisation of polarisation transfer efficiency into quinoline ...... 183
4.3.1 Effect of changing temperature during the polarisation transfer step on polarisation transfer efficiency into quinoline ...... 183
4.3.1.1 Effect of temperature during the polarisation transfer step on polarisation transfer efficiency into quinoline using IMes(c) ...... 183 9
4.3.1.2 Effect of temperature during the polarisation transfer step on polarisation transfer efficiency into quinoline using SIMes(c) ...... 185
4.3.1.3 Effect of temperature during the polarisation transfer step on polarisation transfer efficiency into quinoline using ICy(c) ...... 186
4.3.1.4 Comparison of the effect of temperature during the polarisation transfer step on polarisation transfer efficiency into quinoline using IMes(c) , SIMes(c) and ICy(c) ...... 187
4.3.2 Effect of changing magnetic field during the polarisation transfer step on polarisation transfer efficiency into quinoline ...... 189
4.3.3 Effect of changing concentration on polarisation transfer efficiency into quinoline ...... 191
4.3.4 Effect of changing solvent on polarisation transfer efficiency into quinoline ...... 192
4.4 Mechanism of polarisation transfer into quinoline using SABRE ...... 193
4.4.1 Polarisation of quinoline derivatives ...... 195
4.4.1.1 Naphthalene ...... 195
4.4.1.2 Investigation into the effect of changing the position of the nitrogen on polarisation transfer efficiency ...... 195
4.4.1.3 Investigation into the effect of moving a methyl group of methylquinolines on polarisation transfer efficiency ...... 197
4.4.1.4 Phenazine ...... 199
4.4.2 Investigations in polarisation transfer route into quinoline using the selective OPSYdq sequence ...... 200
4.5 Summary ...... 204
5 Chapter 5 – Implementing SABRE with advanced NMR methods ...... 206 10
5.1 Introduction ...... 206
5.2 Development of method 2 applied to 1D NMR sequences ...... 207
5.2.1 Method 2 applied to 1D 1H NMR sequences ...... 207
5.2.1.1 Investigations into the effect of changing exposure time to para hydrogen on resultant 1H NMR spectra ...... 207
5.2.1.2 Method 2 applied to 1H OPSY NMR sequence ...... 208
5.2.1.3 Method 2 applied to 1H NOESY NMR sequence ...... 209
5.2.2 Method 2 applied to 1D 13 C and 13 C{ 1H} NMR sequences ...... 212
5.2.2.1 Method 2 applied to utilising 13 C magnetisation without 1H decoupling ...... 213
5.2.2.2 Method 2 applied to utilising 13 C magnetisation with 1H decoupling ...... 217
5.2.2.3 Method 2 applied to 13 C INEPT NMR sequences ...... 225
5.2.2.4 Method 2 applied to 1H decoupling of the INEPT sequence ...... 237
5.2.2.5 Utilisation of polarisation transfer to two different nuclei to increase information gain ...... 239
5.2.2.6 Hyperpolarised 13 C NMR spectra using standard reagent concentrations ...... 243
5.3 Development of method 2 applied to 2D NMR sequences ...... 244
5.3.1 Method 2 applied to 1H 1H 2D homonuclear NMR sequences ...... 244
5.3.1.1 Method 2 applied to 1H 1H COSY NMR sequence ...... 245
5.3.1.2 Method 2 applied to 1H 1H OPSYdq COSY NMR sequence ...... 245
5.3.2 Method 2 applied to 1H 13 C 2D heteronuclear NMR sequences...... 248 11
5.3.2.1 Method 2 applied to the 1H 13 C HSQC NMR sequence ...... 248
5.3.2.2 Method 2 applied to the 1H 13 C HMBC NMR sequence ...... 250
5.3.2.3 Method 2 applied to the 1H 13 C HMQC NMR sequence...... 253
5.3.2.4 Investigations into removal of artefacts observed in hyperpolarised 2D NMR spectra ...... 256
5.4 Development of method 1 applied to 2D NMR sequences ...... 259
5.4.1 Method 1 applied to 1H 1H 2D homonuclear NMR sequences ...... 260
5.5 Summary ...... 263
6 Chapter 6 – Applying SABRE ...... 269
6.1 Introduction ...... 269
6.2 Investigations into polarisation transfer efficiency to pyridine analogues ..... 275
6.2.1 The effect of basicity on the level of observed polarisation transfer in a series of para substituted pyridines ...... 275
6.2.2 Effect of substitution on the level of polarisation transfer to the binding pyridine ring and substituents ...... 280
6.2.2.1 Polarisation transfer efficiency trends observed within the methylpyridines ...... 281
6.2.2.2 Polarisation transfer efficiency trends observed within the phenylpyridines ...... 282
6.2.2.3 Polarisation of 3 benzoylpyridine and 4 (4 chlorobenzoyl)pyridine ...... 284
6.3 Polarisation of substrates without a pyridine subunit ...... 286
6.3.1 Investigation into the polarisation of indole ...... 286
6.3.2 Investigation into the polarisation of thiazole ...... 287 12
6.3.2.1 Investigation into the polarisation of 2 aminothiazole ...... 287
6.3.2.2 Investigation into the polarisation of 2 amino 4 methyl thiazole, 2 amino 4 phenyl thiazole and 2 amino 4 (4 chlorophenyl) thiazole ...... 290
6.3.2.3 Investigation into the polarisation of benzothiazole ...... 292
6.3.3 Polarisation of commercial drugs...... 294
6.4 Effect of polarisation transfer efficiency in complex mixtures ...... 295
6.4.1 Effect of polarisation transfer efficiency to competing substrates ...... 295
6.4.1.1 Competition between pyridine and 2 aminothiazole ...... 296
6.4.1.2 Competition between 2 aminothiazole and quinoline ...... 298
6.4.1.3 Competition between 4 methylpyridine and 4 phenylpyridine ...... 300
6.4.2 Utilisation of the 1H OPSYdq NMR sequence ...... 302
6.5 Reaction of 4 carboxaldehydepyridine with methanol ...... 304
6.5.1 The spontaneous reaction of 4 carboxaldehydepyridine with methanol. 305
6.5.2 Monitoring the spontaneous reaction of 4 carboxaldehydepyridine with methanol using SABRE ...... 310
6.5.3 The acid catalysed reaction of 4 carboxaldehydepyridine with methanol ...... 312
6.5.4 Monitoring the acid catalysed reaction of 4 carboxaldehydepyridine with methanol using SABRE ...... 315
6.6 Summary ...... 317
7 Chapter 7 – Conclusions and future work ...... 319
7.1 Conclusions ...... 319
7.2 Future work ...... 324 13
8 Chapter 8 – Experimental ...... 327
8.1 Instrumentation and chemical sources...... 327
8.1.1 NMR spectrometers ...... 327
8.1.2 Preparation of para hydrogen ...... 327
8.1.3 Source of solvents and chemicals ...... 328
8.2 Standard methods ...... 328
8.2.1 Hyperpolarisation method 1 – shake method ...... 328
8.2.2 Hyperpolarisation method 2 – flow method...... 328
8.2.3 Calculation of 1H NMR enhancement factors ...... 329
8.2.4 Considerations when discussing the effect of the magnetic field of polarisation on polarisation transfer efficiency ...... 330
8.2.5 Effect of changing PTF on the polarisation transfer efficiency into various substrates ...... 332
8.2.5.1 Effect of changing PTF on polarisation transfer efficiency into pyridine with SIMes(a) ...... 332
8.2.5.2 Effect of changing PTF on polarisation transfer efficiency into pyridine using ICy(a) ...... 333
8.2.5.3 Effect of changing PTF on polarisation transfer efficiency into
pyridine using ICy 2(a) ...... 334
8.2.5.4 Effect of changing PTF on polarisation transfer efficiency into 3,4,5
d3 pyridine using SIMes(a) ...... 335
8.2.5.5 Effect of changing PTF on polarisation transfer efficiency into quinoline using IMes(b) ...... 336
8.2.5.6 Effect of changing PTF on polarisation transfer efficiency into 4 methylpyridine using SIMes(a) ...... 337 14
8.2.5.7 Effect of changing PTF on polarisation transfer efficiency into 3 methylpyridine using SIMes(a) ...... 338
8.2.5.8 Effect of changing PTF on polarisation transfer efficiency into 2 aminothiazole using IMes(a) ...... 339
8.2.5.9 Effect of changing PTF on polarisation transfer efficiency into 3 phenylpyridine using IMes(a) ...... 340
8.2.5.10 Effect of changing PTF on polarisation transfer efficiency into 4 phenylpyridine using IMes(a) ...... 341
8.2.6 Calculation of rate constants for ligand loss and thermodynamic activation parameters ...... 342
8.2.7 Procedure for investigating the effect of changing temperature of polarisation on polarisation transfer efficiency ...... 342
8.3 Additional experiments ...... 343
8.3.1 Relative excess of hydrogen gas present in an NMR sample interrogated using method 1 ...... 343
8.3.2 Calculations relating to the solubility of hydrogen gas in methanol ...... 344
8.3.2.1 Calculations based on equations reported in Solubility of Gases in Liquids 212 ...... 344
8.3.2.2 Calculations based on equations reported by Liu et al .214 ...... 345
8.3.3 Calculation of estimated integrals of thermally polarised spectra for low concentration samples ...... 346
8.3.4 Thermally polarised spectra of quinoline using standard concentrations for comparison ...... 348
8.4 Reactions ...... 349
215 8.4.1 [Ir(COD)Cl] 2 ...... 349 15
216 8.4.2 [Ir(µ MeO)(COD)] 2 ...... 350
8.4.3 [Ir(IMes)(COD)Cl] 104 (IMes(a) ) ...... 350
80 8.4.4 [Ir(IMes)(COD)NCMe]PF 6 (IMes(b) ) ...... 351
8.4.5 [Ir(SIMes)(COD)Cl] 104 (SIMes(a) ) ...... 351
80 8.4.6 [Ir(SIMes)(COD)NCMe]PF 6 (SIMes(b) ) ...... 351
8.4.7 Bis 1,3 cyclohexyl imidazole hydrochloride (ICy.HCl) 217 ...... 351
8.4.8 [Ir(ICy)(COD)Cl] 104 (ICy(a) ) ...... 352
104 8.4.9 [Ir(ICy) 2(COD)]Cl (ICy 2(a) ) ...... 352
8.5 Characterisation of catalyst precursors and active polarisation transfer catalysts ...... 353
8.5.1 [Ir(COD)Cl] 2 ...... 353
8.5.2 [Ir(µ MeO)(COD)] 2 ...... 353
8.5.3 [Ir(IMes)(COD)Cl] ( IMes(a) ) ...... 353
8.5.4 [Ir(IMes)(py) 3(H) 2]Cl ...... 353
8.5.5 [Ir(IMes)(quinoline) 2(H) 2(NCMe)]Cl ...... 354
8.5.6 [Ir(IMes)(COD)(NCMe)]PF 6 (IMes(b) ) ...... 358
8.5.7 [Ir(SIMes)(COD)Cl] ( SIMes(a) ) ...... 358
8.5.8 [Ir(SIMes)(py) 3(H) 2]Cl ...... 358
8.5.9 Bis 1,3 cyclohexyl imidazole hydrochloride (ICy.HCl) ...... 359
8.5.10 [Ir(ICy)(COD)Cl] ( ICy(a) ) ...... 359
8.5.11 [Ir(ICy)(py) 3(H) 2]Cl ...... 359